AI drug discovery company

Relation Therapeutics

Data as of Oct 17, 2026.

Company facts

Founded

2019

ReportedSource for founded (opens in new tab)
Headquarters

United Kingdom (London)

ConfirmedSource for headquarters (opens in new tab)
Total funding

$60M

ConfirmedSource for total funding (opens in new tab)

Latest funding round

Round: Further investment
Date: Dec 9, 2025
Amount: $26M
Lead investor: NVentures, DCVC and Magnetic Ventures (no single lead named)

ConfirmedSource for the latest round (opens in new tab)

Drug discovery partners

2 pharma. Pharma here means a company with approved products and roughly $1B or more in annual revenue.

GSK Pharma

Expanded collaboration, Jul 30, 2026

Terms not disclosed

ConfirmedSource for GSK (opens in new tab)
Novartis Pharma

Target discovery collaboration, Dec 9, 2025

$55M upfront ($1.7B total potential)

ConfirmedSource for Novartis (opens in new tab)

Big tech ties

Not counted as pharma partners.

NVIDIA (NVentures)

Investor (2024 seed co-lead; 2025 round), Dec 9, 2025

ConfirmedSource for NVIDIA (NVentures) (opens in new tab)

Recent news

Jul 30, 2026

Expanded GSK collaboration to deploy MORGAN cellular foundation model

ConfirmedSource (opens in new tab)
Jan 7, 2026

Agrees with Deerfield to potentially form new companies around targets from its AI discovery work

ReportedSource (opens in new tab)
Dec 9, 2025

Collaboration with Novartis on drug targets for atopic diseases

ConfirmedSource (opens in new tab)
Dec 9, 2025

Further investment: $26M

ConfirmedSource (opens in new tab)

Confirmed means the company, a partner or a filing said it. Reported means a third party said it. This section sits outside the Pharma AI Tracker.

Spot an error? Tell me and I'll fix it.